Public Health Funding Restoration Act

CDC Funding in FY 2025 Labor, Health and Human Services bill, including immunization, smoking and health, social determinants of health, injury and violence prevention, public health preparedness, epi and lab capacity, Data Modernization, Center for Forecasting Outbreak and Analytics, overdose prevention, public health workforce, capacity and infrastructure, infectious diseases Overdose prevention, Modernizing Opioid Treatment Access Act (H.R. 1359/S. 644) Regulation of Tobacco/Nicotine and flavors Extension of federal flexibilities for teleprescribing of controlled substances H.R. 6663/S. 3364, Kid Providing Resources for Optimal Outcomes Against Fatalities (Kid PROOF) Act Reauthorization of the Pandemic and All-Hazards Preparedness Act H.R. 9886/S. 5271, Broadening Utilization of Proven and Effective Treatment for Recovery Act H.R. 10126/S. 5326 Public Health Funding Restoration Act

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to lung disease treatment, prevention and research; public health; tobacco control and air pollution; Issues related to the Affordable Care Act; Issues related to COVID-19 Response; Issues related to infrastructure; Issues relating to FY25 appropriations; Issues relating to the Presidents FY26 budget; HR 9027 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025; H.R. 8774 Department of Defense Appropriations Act 2025; HR 8998 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2025; HR 9029 Departments of Labor, Health and Human Services, and Education, and related agencies Act, 2025 ; H.R. 8773, Financial Services and General Government Appropriations, Act 2025; HR 9028 Transportation Housing and Urban Development and Related Agencies Appropriations Act, 2025; S. 4942 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025; S 4928 Financial Services and General Government Appropriations Act, 2025; S 4802 Department of the Interior, Environment and Related Agencies Act, 2025; S 4796 Transportation Housing and Urban Development and Related Agencies Appropriations Act, 2025; S 4690 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2025; S 4921 Department of Defense Appropriations Act 2025; S 4928 Financial Services and General Government Appropriations Act, 2025; S 5326 Public Health Funding Restoration Act; HR 10126 Public Health Funding Restoration Act HR 10515, American Relief Act, 2025; HR 10545, American Relief Act, 2025

Client expense: $60,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE

Lobbying Report: October 1st - December 31st, 2024 (Campaign) Federal (under tobacco issue code) Legislation: S.4690/H.R. 9027 - FY 25 Agriculture, Rural Development, and Food and Drug Administration, and Related Agencies Appropriations Bill S.4942/H.R. 9029 - FY 25 Labor, HHS, Education, and Related Agencies Appropriations Bill ENND Act S. 5326/H.R. 10126 Public Health Funding Restoration Act H.R. 9425 - Tobacco User Fee Modernization Act of 2024 H.R. 4775 - Helping Tobacco Users Quit Act Stop Chinese Vapes from Poisoning American Kids Act Issues FDA proposed rule on menthol cigarettes FDA proposed rule on flavored cigars FDA regulation of e-cigarettes DA tobacco product review and enforcement FDA nicotine standard Youth e-cigarette use CDC Office on Smoking and Health funding Agencies Visited: Centers for Disease Control and Prevention US House of Representatives US Senate Food and Drug Administration Domestic Policy Council Office of the Vice President

Client expense: $140,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, SENATE